BioTelemetry (BEAT) Tops Q3 EPS by 4c

February 26, 2014 4:27 PM

BioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.00, $0.04 better than the analyst estimate of ($0.04). Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found